Cargando…
PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN
Peritoneal metastasis is the most frequent cause of death in patients with advanced gastric carcinoma (GC). The phosphatase of regenerating liver-3 (PRL-3) is recognized as an oncogene and plays an important role in GC peritoneal metastasis. However, the mechanism of how PRL-3 regulates GC invasion...
Autores principales: | Xiong, Jianbo, Li, Zhengrong, Zhang, Yang, Li, Daojiang, Zhang, Guoyang, Luo, Xianshi, Jie, Zhigang, Liu, Yi, Cao, Yi, Le, Zhibiao, Tan, Shengxing, Zou, Wenyu, Gong, Peitao, Qiu, Lingyu, Li, Yuanyuan, Wang, Huan, Chen, Heping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022899/ https://www.ncbi.nlm.nih.gov/pubmed/27572739 http://dx.doi.org/10.3892/or.2016.5030 |
Ejemplares similares
-
PRL-3 promotes gastric cancer peritoneal metastasis via the PI3K/AKT signaling pathway in vitro and in vivo
por: Zhang, Yang, et al.
Publicado: (2018) -
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2019) -
PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021) -
Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2021) -
PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia
por: Carlock, Colin, et al.
Publicado: (2023)